Cohen & Steers, Inc. (CNS) AI Stock Analysis

NYSE: CNSAI research summary: business, growth, valuation, analysts, bull and bear case.

CNS AI stock analysis summary

AI Research

Cohen & Steers, Inc. (CNS) is an asset management firm specializing in real estate, infrastructure, and multi-asset strategies. Trailing twelve months revenue reached $599.6M with an operating margin of 32.4%, supported by a net cash position of $477.8M. The stock offers a 3.85% dividend yield and trades at a forward P/E of 18.5x.

Market cap
$3.58B
Revenue (TTM)
$599.6M
P/E
21.4x
fwd 18.5x
1Y return
9.8%
S&P 500 16.8%
Avg. target
$71.67
2.9% vs last close

Bull case

  • Trailing twelve months revenue rose 11.1% year-over-year in the latest quarter, reaching $599.6M.
  • The balance sheet maintains $477.8M in net cash with a low debt-to-equity ratio of 0.23.
  • Shareholders receive a 3.85% dividend yield backed by 23 consecutive years of dividend payments.

Bear case

  • FY2025 free cash flow was -$126.4M, down significantly from $85.0M generated in FY2024.
  • The stock trades at a forward P/E of 18.5x, well above the peer group median of 10.8x.
  • Five-year stock performance of -6.2% significantly trailed the S&P 500 return of 83.0%.

What Cohen & Steers does

Cohen & Steers, Inc. is an asset management holding company that serves institutional investors such as pension funds, endowments, and foundations, as well as retail clients. Established in 1986 and based in New York, the firm operates globally across locations including London, Hong Kong, Tokyo, and Seattle. Cohen & Steers manages portfolios across equity, fixed income, multi-asset, and commodity strategies, and also oversees mutual funds and hedge funds. The firm focuses particularly on global economic infrastructure sectors, including real estate investment trusts (REITs), infrastructure development, and natural energy resources.

Growth and profitability

Revenue rose from $489.6M in FY2023 to $517.4M in FY2024 and $567.8M in FY2025, reflecting 9.7% annual growth in FY2025. Gross margin expanded to 57.5% in FY2025 from 46.8% in FY2024, though operating margin declined slightly from 33.4% to 31.3%. Net income totaled $153.2M in FY2025 with diluted earnings per share of $3.10. For the trailing twelve months ended September 30, 2026, revenue stood at $599.6M, supported by latest quarter revenue growth of 11.1% year-over-year. Operating margin for the trailing twelve months was 32.4%, and net profit margin was 28.2%.

CNS income statement →

Balance sheet and cash flow

As of June 30, 2026, Cohen & Steers held $612.2M in cash and short-term investments against $134.4M in total debt, yielding net cash of $477.8M. The current ratio stood at 2.66 and the debt-to-equity ratio was 0.23. In FY2025, operating cash flow was -$120.4M and free cash flow was -$126.4M, with capital expenditures of $6.0M. During FY2025, cash deployment included $126.9M in dividends paid and $28.4M allocated to share buybacks.

CNS balance sheet →

Valuation and performance

At $69.63, Cohen & Steers trades at a trailing P/E of 21.4x and a forward P/E of 18.5x, representing a premium to the median of its US-listed Financial Services peers of 12.1x trailing and 10.8x forward. Its price-to-sales ratio is 6.0x, above the peer median of 3.2x, while EV to EBITDA is 16.3x versus the peer median of 11.7x. Over the past year, the stock returned 9.8%, trailing the S&P 500 (SPY) return of 16.8%. Over five years, the stock returned -6.2% compared to an 83.0% gain for the benchmark.

CNS key metrics →

CNS dividend

Cohen & Steers pays a quarterly dividend with an annualized forward payout of $2.68 per share, representing a dividend yield of 3.85%. The payout ratio is 63.4%, and the company has paid dividends for 23 consecutive years. Over the past five years, the dividend has grown at an annualized rate of 9.7%. The last ex-dividend date was August 10, 2026.

CNS dividend history →

What analysts expect

Wall Street coverage includes 3 ratings: 1 Strong Buy, 1 Hold, and 1 Sell. The mean price target is $71.67, indicating 2.9% upside compared to the last close of $69.63. For the fiscal year ending December 31, 2026, analysts estimate EPS of $3.52, an increase of 13.9%, on revenue of $612.5M. For the following fiscal year, 3 analysts project EPS of $3.74 on revenue of $646.4M. Over the last four quarters, the company beat EPS estimates 2 times.

CNS forecast and price target →

Key risks and what to watch

  • Free cash flow dropped to -$126.4M in FY2025, which could pressure capital return if negative cash generation persists.
  • Operating margin of 31.3% in FY2025 sits below the 44.6% achieved in FY2021.
  • The stock carries a beta of 1.22, indicating greater price volatility than the broader equity market.
  • Earnings track record shows inconsistent forecasting, with only 2 EPS beats across the last 4 quarters.

AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer

About this CNS AI stock analysis

This page is an AI-written research summary of Cohen & Steers, Inc. (CNS). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: CNS income statement, CNS balance sheet, CNS key metrics, CNS analyst forecast, CNS chart. See the CNS stock overview for the latest quote and news.

CNS AI stock analysis FAQ

What is Cohen & Steers' dividend yield and payment schedule?

Cohen & Steers pays a quarterly dividend with a forward annual payout of $2.68 per share, which equals a 3.85% dividend yield. The firm has paid dividends for 23 consecutive years.

What is Cohen & Steers' balance sheet position?

As of June 30, 2026, the company held $612.2M in cash and short-term investments and $134.4M in total debt, resulting in net cash of $477.8M and a debt-to-equity ratio of 0.23.

What are analysts forecasting for CNS earnings?

For the fiscal year ending December 31, 2026, analysts expect EPS of $3.52 on revenue of $612.5M. For the next fiscal year, analysts project EPS of $3.74 and revenue of $646.4M.

How does CNS valuation compare to its peer group?

CNS trades at a forward P/E of 18.5x and price-to-sales of 6.0x, above the US-listed Financial Services median forward P/E of 10.8x and price-to-sales median of 3.2x.

More Financial Services AI stock analysis